サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：ミノキシジルの世界市場規模：製品別（5％、2％）、地域別、価格分析・予測、2023年～2032年
市場調査レポート
商品コード
1248112

ミノキシジルの世界市場規模：製品別（5％、2％）、地域別、価格分析・予測、2023年～2032年

Minoxidil Market Size, By Product (5%, 2%), By Region, Pricing Analysis & Global Forecast, 2023 - 2032
出版日: | 発行: Global Market Insights Inc. | ページ情報: 英文 240 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.53円
ミノキシジルの世界市場規模：製品別（5％、2％）、地域別、価格分析・予測、2023年～2032年
出版日: 2023年03月24日
発行: Global Market Insights Inc.
ページ情報: 英文 240 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のミノキシジル市場は、円形脱毛症の有病率の上昇とそれに伴うパーソナルケア製品の販売急増により、2023年から2032年にかけて大きく成長すると予測されています。

円形脱毛症の有病率は約1000人に1人、生涯リスクは2％と推定されています。ミノキシジルは、毛髪の成長を促し、脱毛を防ぐために使用されます。

新興諸国の人々のライフスタイルが常に進化し、購買力が高まっていることは、市場の拡大にプラスの影響を与えるでしょう。また、多機能パーソナルケア成分分野の堅調な成長も、市場の需要を促進することになるでしょう。信頼できる情報源によると、中国、インド、ブラジル、メキシコ、インドネシア、サウジアラビアは、ミノキシジル市場のホットスポットとみなされています。これらの経済圏は、先進国の多くが大人になるにつれて、パーソナルケアの収益性の高い市場へと変化していきます。

この市場で活動する企業は、業界での競争力を高めるために、M&A、パートナーシップ、研究開発投資、新製品の発売などの戦略的な取り組みを行っています。例えば、ViaDerma, Inc.は最近、ミノキシジルを使用した新しい発毛製品を発表する計画を発表しました。この新製品は、より多くの活性物質を皮膚に吸収させることができるため、より良く、より速く作用し、従来の局所療法よりも顕著に優れた効果をもたらすことが頻繁にあります。

全体として、ミノキシジル産業は製品および地域の点で区分されます。

製品別では、2032年までに2%製品セグメントが顕著な利益を占めると予測されています。特に男性人口の間で増加している前頭部のはげの問題は、今後数年間、ミノキシジル製品の使用を促進するでしょう。米国国立衛生研究所の統計によると、40～55歳の男性の約25％、65～69歳の男性の31％に、前頭部の生え際の後退が観察されました。また、抜け毛が多いという問題が絶えず発生していることから、男性の間で髪の健康に対する関心が高まっており、推定期間中に製品需要が増加すると考えられています。

地域別では、アジア太平洋地域のミノキシジル産業は、2032年までに2億米ドル以上の規模になると予測されています。人口の増加、外見に対する意識と関心の高まりが、予測期間中の地域市場の成長にプラスの影響を与えるでしょう。さらに、インド、中国、日本の人口の間で、薄毛や抜け毛の苦情が増加しており、ミノキシジルを配合した製剤の需要をさらに押し上げると考えられます。インドでは人口の40％が薄毛に悩んでおり、その根本的な原因はホルモンバランスの乱れであると報告されています。

目次

第1章 調査手法とスコープ

第2章 エグゼクティブサマリー

第3章 ミノキシジルの業界洞察

  • 業界別セグメンテーション
  • COVID-19世界経済への影響について
  • 産業エコシステム分析
    • 原材料
    • メーカー
    • 販売店
    • 流通チャネル分析
    • 利益率の動向
    • ベンダーマトリクス
    • COVID-19がバリューチェーンに与える影響
  • 原材料の分析
    • COVID-19の原料供給への影響について
  • テクノロジー情勢
    • 想定されるアプリケーションシナリオ
      • ヒゲの成長にミノキシジルを
      • ミノキシジルの代替製剤
    • 製剤化プロセス
    • 固体脂質ナノ粒子
    • プロピレングリコールミノキシジル外用剤（脱毛症用
  • 世界の脱毛症産業シナリオ
    • ミノキシジルと他の薄毛治療薬の比較
      • ミノキシジルの皮膚科での使用
        • ヘアトランスプラント
        • 円形脱毛症
      • ミノキシジルの副作用
      • その他の薄毛治療薬
        • アンドロゲン依存性薬物
      • 2018年、2019年、2020年、2021年、2022年の新規ユーザー数％
        • 人口動態の推移
        • 消費者の購買行動
        • アンメットニーズ
        • 社会的・文化的影響力
        • 情報検索
        • 代替案の評価
        • 購入決定
        • 購入後の評価
    • COVID-19が消費者の購買行動に与える影響
  • 業界のベストプラクティスと主要な購入基準
  • 規制状況について
    • 北米
      • 保健福祉省（NDA 021812/S-009）
    • 欧州
      • 医薬品・ヘルスケア製品規制庁（PL 15513/0135-0020）
    • アジア太平洋地域
      • 独立行政法人医薬品医療機器総合機構（PMDA）
    • ラテンアメリカ
      • アルゼンチンのレアルタッド・コマーシャル法
      • ブラジル規則335/99
    • 中東・アフリカ地域
      • サウジアラビア食品医薬品局（SFDA：Saudi Food &Drug Authority）
  • 価格分析、地域別
    • 5%ミノキシジル
    • 2%ミノキシジル
    • コスト構造分析
    • COVID-19のリージョナル価格への影響
  • 業界への影響要因
    • 促進要因
      • ヘアケア製品への消費意欲の高まりと流通チャネルの拡大
      • 円形脱毛症の増加とともにパーソナルケア市場の開拓が進む
    • 業界の落とし穴
      • ミノキシジルの副作用の可能性とともに厳しい規制がある
  • イノベーションとサステナビリティ
  • 成長性分析、2022年
  • ポーター分析
  • PESTEL分析
  • COVID-19の化粧品業界への影響について
  • ロシア・ウクライナ戦争がミノキシジル市場に与える影響について

第4章 競合情勢、2022年

  • イントロダクション
  • 企業シェア分析、2022年
    • 北米の企業シェア分析、2022年
    • 欧州企業シェア分析、2022年
    • APAC企業シェア分析、2022年
    • LATAM企業シェア分析、2022年
    • MEA企業シェア分析、2022年
  • 主要市場プレイヤーの競合分析
    • Johnson & Johnson Consumer Inc.
    • Costco Wholesale Corporation
    • Perrigo Company Plc
    • Pfizer
    • Renata
  • 競合のポジショニングマトリックス
  • 戦略的展望マトリクス

第5章 ミノキシジル市場：製品別

  • 主な製品動向
  • 5%
  • 2%

第6章 ミノキシジル市場：地域別内訳

  • 主な地域動向
  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • ロシア
    • ポーランド
  • アジア太平洋地域
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • インドネシア
    • タイ
    • マレーシア
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • アルゼンチン
  • 中東・アフリカ地域
    • サウジアラビア
    • UAE
    • 南アフリカ

第7章 企業プロファイル

  • Nanz Med Science Pharma Private Limited
  • Bakul Group of companies
  • Kumar Organic Products Limited
  • Changzhou Tianhua Pharmaceutical Co., Ltd.
  • Par Pharmaceuticals
  • Provizer Pharma
  • Metapharmaceutical Ind. S.L.
  • Pharhome International Limited
  • LOY Pharma Lab, Inc.
  • Maruti Futuristic Pharma Pvt. Ltd.
  • Dr. R. Pfleger Chemical Factory GmbH
  • Renata Limited
  • McNeil Consumer Healthcare
  • Pfizer
図表

Data Tables

  • TABLE 1 Global minoxidil market, 2018-2032, (Thousand Units) (USD Million)
  • TABLE 2 Global minoxidil market estimates & forecast, by region, 2018-2032, (Thousand Units)
  • TABLE 3 Global minoxidil market estimates & forecast, by region, 2018-2032, (USD Million)
  • TABLE 4 Global minoxidil market estimates and forecast by product, 2018-2032 (Thousand Units)
  • TABLE 5 Global minoxidil market estimates and forecast by product, 2018-2032 (USD Million)
  • TABLE 6 Vendor matrix
  • TABLE 7 Bionanoplus' propylene glycol free minoxidil formulation
  • TABLE 8 Bionanoplus' propylene glycol free minoxidil properties across a year
  • TABLE 9 New users % for 2018, 2019, 2020, 2021, and 2022
  • TABLE 10 Industry best practices & key buying criteria
  • TABLE 11 Pharmaceutical and Medical Devices Agency Classification of drugs
  • TABLE 12 Competitive analysis of major market players
  • TABLE 13 Vendor adoption matrix: Classification criteria
  • TABLE 14 Market estimates & forecast, 2018-2032 (Thousand Units) (USD Million)
  • TABLE 15 Market estimates & forecast, 2018-2032 (Thousand Units)
  • TABLE 16 Market estimates & forecast, 2018-2032 (USD Million)
  • TABLE 17 Market estimates & forecast, 2018-2032 (Thousand Units) (USD Million)
  • TABLE 18 Market estimates & forecast, 2018-2032 (Thousand Units)
  • TABLE 19 Market estimates & forecast, 2018-2032 (USD Million)
  • TABLE 20 Market estimates & forecast, 2018-2032 (Thousand Units) (USD Million)
  • TABLE 21 Market estimates and forecast by product, 2018-2032 (Thousand Units)
  • TABLE 22 Market estimates and forecast by product, 2018-2032 (USD Million)
  • TABLE 23 Market estimates & forecast, 2018-2032 (Thousand Units) (USD Million)
  • TABLE 24 Market estimates and forecast by product, 2018-2032 (Thousand Units)
  • TABLE 25 Market estimates and forecast by product, 2018-2032 (USD Million)
  • TABLE 26 Market estimates & forecast, 2018-2032 (Thousand Units) (USD Million)
  • TABLE 27 Market estimates and forecast by product, 2018-2032 (Thousand Units)
  • TABLE 28 Market estimates and forecast by product, 2018-2032 (USD Million)
  • TABLE 29 Market estimates & forecast, 2018-2032 (Thousand Units) (USD Million)
  • TABLE 30 Market estimates and forecast by product, 2018-2032 (Thousand Units)
  • TABLE 31 Market estimates and forecast by product, 2018-2032 (USD Million)
  • TABLE 32 Market estimates & forecast, 2018-2032 (Thousand Units) (USD Million)
  • TABLE 33 Market estimates and forecast by product, 2018-2032 (Thousand Units)
  • TABLE 34 Market estimates and forecast by product, 2018-2032 (USD Million)
  • TABLE 35 Market estimates & forecast, 2018-2032 (Thousand Units) (USD Million)
  • TABLE 36 Market estimates and forecast by product, 2018-2032 (Thousand Units)
  • TABLE 37 Market estimates and forecast by product, 2018-2032 (USD Million)
  • TABLE 38 Market estimates & forecast, 2018-2032 (Thousand Units) (USD Million)
  • TABLE 39 Market estimates and forecast by product, 2018-2032 (Thousand Units)
  • TABLE 40 Market estimates and forecast by product, 2018-2032 (USD Million)
  • TABLE 41 Market estimates & forecast, 2018-2032 (Thousand Units) (USD Million)
  • TABLE 42 Market estimates and forecast by product, 2018-2032 (Thousand Units)
  • TABLE 43 Market estimates and forecast by product, 2018-2032 (USD Million)
  • TABLE 44 Market estimates & forecast, 2018-2032 (Thousand Units) (USD Million)
  • TABLE 45 Market estimates and forecast by product, 2018-2032 (Thousand Units)
  • TABLE 46 Market estimates and forecast by product, 2018-2032 (USD Million)
  • TABLE 47 Market estimates & forecast, 2018-2032 (Thousand Units) (USD Million)
  • TABLE 48 Market estimates and forecast by product, 2018-2032 (Thousand Units)
  • TABLE 49 Market estimates and forecast by product, 2018-2032 (USD Million)
  • TABLE 50 Market estimates & forecast, 2018-2032 (Thousand Units) (USD Million)
  • TABLE 51 Market estimates and forecast by product, 2018-2032 (Thousand Units)
  • TABLE 52 Market estimates and forecast by product, 2018-2032 (USD Million)
  • TABLE 53 Market estimates & forecast, 2018-2032 (Thousand Units) (USD Million)
  • TABLE 54 Market estimates and forecast by product, 2018-2032 (Thousand Units)
  • TABLE 55 Market estimates and forecast by product, 2018-2032 (USD Million)
  • TABLE 56 Market estimates & forecast, 2018-2032 (Thousand Units) (USD Million)
  • TABLE 57 Market estimates and forecast by product, 2018-2032 (Thousand Units)
  • TABLE 58 Market estimates and forecast by product, 2018-2032 (USD Million)
  • TABLE 59 Market estimates & forecast, 2018-2032 (Thousand Units) (USD Million)
  • TABLE 60 Market estimates and forecast by product, 2018-2032 (Thousand Units)
  • TABLE 61 Market estimates and forecast by product, 2018-2032 (USD Million)
  • TABLE 62 Market estimates & forecast, 2018-2032 (Thousand Units) (USD Million)
  • TABLE 63 Market estimates and forecast by product, 2018-2032 (Thousand Units)
  • TABLE 64 Market estimates and forecast by product, 2018-2032 (USD Million)
  • TABLE 65 Market estimates & forecast, 2018-2032 (Thousand Units) (USD Million)
  • TABLE 66 Market estimates and forecast by product, 2018-2032 (Thousand Units)
  • TABLE 67 Market estimates and forecast by product, 2018-2032 (USD Million)
  • TABLE 68 Market estimates & forecast, 2018-2032 (Thousand Units) (USD Million)
  • TABLE 69 Market estimates and forecast by product, 2018-2032 (Thousand Units)
  • TABLE 70 Market estimates and forecast by product, 2018-2032 (USD Million)
  • TABLE 71 Market estimates & forecast, 2018-2032 (Thousand Units) (USD Million)
  • TABLE 72 Market estimates and forecast by product, 2018-2032 (Thousand Units)
  • TABLE 73 Market estimates and forecast by product, 2018-2032 (USD Million)
  • TABLE 74 Market estimates & forecast, 2018-2032 (Thousand Units) (USD Million)
  • TABLE 75 Market estimates and forecast by product, 2018-2032 (Thousand Units)
  • TABLE 76 Market estimates and forecast by product, 2018-2032 (USD Million)
  • TABLE 77 Market estimates & forecast, 2018-2032 (Thousand Units) (USD Million)
  • TABLE 78 Market estimates and forecast by product, 2018-2032 (Thousand Units)
  • TABLE 79 Market estimates and forecast by product, 2018-2032 (USD Million)
  • TABLE 80 Market estimates & forecast, 2018-2032 (Thousand Units) (USD Million)
  • TABLE 81 Market estimates and forecast by product, 2018-2032 (Thousand Units)
  • TABLE 82 Market estimates and forecast by product, 2018-2032 (USD Million)
  • TABLE 83 Market estimates & forecast, 2018-2032 (Thousand Units) (USD Million)
  • TABLE 84 Market estimates and forecast by product, 2018-2032 (Thousand Units)
  • TABLE 85 Market estimates and forecast by product, 2018-2032 (USD Million)
  • TABLE 86 Market estimates & forecast, 2018-2032 (Thousand Units) (USD Million)
  • TABLE 87 Market estimates and forecast by product, 2018-2032 (Thousand Units)
  • TABLE 88 Market estimates and forecast by product, 2018-2032 (USD Million)
  • TABLE 89 Market estimates & forecast, 2018-2032 (Thousand Units) (USD Million)
  • TABLE 90 Market estimates and forecast by product, 2018-2032 (Thousand Units)
  • TABLE 91 Market estimates and forecast by product, 2018-2032 (USD Million)
  • TABLE 92 Market estimates & forecast, 2018-2032 (Thousand Units) (USD Million)
  • TABLE 93 Market estimates and forecast by product, 2018-2032 (Thousand Units)
  • TABLE 94 Market estimates and forecast by product, 2018-2032 (USD Million)
  • TABLE 95 Market estimates & forecast, 2018-2032 (Thousand Units) (USD Million)
  • TABLE 96 Market estimates and forecast by product, 2018-2032 (Thousand Units)
  • TABLE 97 Market estimates and forecast by product, 2018-2032 (USD Million)
  • TABLE 98 Market estimates & forecast, 2018-2032 (Thousand Units) (USD Million)
  • TABLE 99 Market estimates and forecast by product, 2018-2032 (Thousand Units)
  • TABLE 100 Market estimates and forecast by product, 2018-2032 (USD Million)
  • TABLE 101 Market estimates & forecast, 2018-2032 (Thousand Units) (USD Million)
  • TABLE 102 Market estimates and forecast by product, 2018-2032 (Thousand Units)
  • TABLE 103 Market estimates and forecast by product, 2018-2032 (USD Million)

Charts & Figures

  • FIG. 1 Market forecasting methodology
  • FIG. 2 Profile break-up of primary respondents
  • FIG. 3 Minoxidil industry 360 degree synopsis, 2022
  • FIG. 4 Age distribution of patients with early-onset androgenetic alopecia
  • FIG. 5 Europe hair care market, 2021 - 2027, (In USD Billion)
  • FIG. 6 Industry segmentation
  • FIG. 7 Industry ecosystem analysis
  • FIG. 8 Profit margin trend
  • FIG. 9 Global urban population by region, 2021 & 2050 (%)
  • FIG. 10 Life expectancy, by country, 2022 & 2050
  • FIG. 11 Global Muslim population by region (%), 2010 & 2050
  • FIG. 12 Cost structure analysis
  • FIG. 13 Asia online pharmacy market, 2021 - 2027 (USD Billion)
  • FIG. 14 BRICS population, 2021
  • FIG. 15 Growth potential analysis, 2022
  • FIG. 16 Porter's analysis
  • FIG. 17 PESTEL analysis
  • FIG. 18 Competitive analysis of major market players, 2022
  • FIG. 19 Competitive positioning matrix
  • FIG. 20 Strategic outlook matrix
  • FIG. 21 SWOT Analysis, Nanz Med Science Pharma Private Limited
  • FIG. 22 SWOT Analysis, Bakul Group of companies
  • FIG. 23 SWOT Analysis, Kumar Organic Products Limited
  • FIG. 24 SWOT Analysis, Changzhou Tianhua Pharmaceutical Co., Ltd.
  • FIG. 25 SWOT Analysis, Par Pharmaceuticals
  • FIG. 26 SWOT Analysis, Provizer Pharma
  • FIG. 27 SWOT Analysis, Metapharmaceutical Ind. S.L.
  • FIG. 28 SWOT Analysis, Pharhome International Limited
  • FIG. 29 SWOT Analysis, LOY Pharma Lab, Inc.
  • FIG. 30 SWOT Analysis, Maruti Futuristic Pharma Pvt. Ltd.
  • FIG. 31 SWOT Analysis, Dr. R. Pfleger Chemical Factory GmbH
  • FIG. 32 SWOT Analysis, Renata Limited
  • FIG. 33 SWOT Analysis, McNeil Consumer Healthcare
目次
Product Code: 750

Minoxidil Market is poised to grow considerably during 2023-2032 owing to the increasing prevalence of alopecia areata and a subsequent surge in personal care product sales. The estimated alopecia areata prevalence is approximately 1 in 1000 people, with a lifetime risk of 2%. Minoxidil is used to encourage hair growth and avert hair loss.

Constantly evolving lifestyles and the increasing purchasing power of people in developing countries will positively influence the market expansion. Besides, the sturdy growth of the multi-functional personal care ingredient segment will also propel the demand for the market. According to credible sources, China, India, Brazil, Mexico, Indonesia, and Saudi Arabia are regarded as the hotspots for minoxidil market. These economies turn into profitable markets for personal care as most industrialized nations enter adulthood.

The firms operating in the market are engaging in strategic initiatives such as mergers and acquisitions, partnerships, R&D investments, and new product launches to gain a competitive edge in the industry. For instance, ViaDerma, Inc. has recently announced plans to unveil a new hair-regrowth product employing Minoxidil. The new product enables far more active substances to be absorbed into the skin, where it can operate better and faster and frequently yield effects that are noticeably superior to those of conventional topical therapies.

Overall, the minoxidil industry is segmented in terms of product and region.

Based on product, the 2% product segment is projected to account for noticeable gains by 2032. The increasing problem of frontal baldness, especially among the male population, will encourage the use of minoxidil products in the coming years. As per National Institutes of Health statistics, a receding frontal hairline was observed in approximately 25% of men between 40-55 years of age, with 31% of men falling in the age category of 65-69. In addition, the constantly surging problem of excessive hair fall has raised concerns among men about hair health, which is estimated to augment product demand during the estimated timeframe.

From the regional perspective, the Asia Pacific minoxidil industry is anticipated to be valued at over USD 200 million by 2032. Increasing population and budding awareness and attention to physical appearance will positively influence the regional market growth over the forecast period. Moreover, mounting complains of hair thinning and hair fall amongst populations in India, China, and Japan would further push the demand for minoxidil infused formulations. It has been reported that 40% of the Indian population suffers from hair loss, with hormonal imbalance being the root cause.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Scope and definitions
    • 1.1.1 Scope & Market Definition
  • 1.1 Base estimates & calculations
  • 1.2 Forecast calculations.
  • 1.3 COVID-19 impact analysis.
    • 1.3.1 North America
    • 1.3.2 Europe
    • 1.3.3 Asia Pacific
    • 1.3.4 Latin America
    • 1.3.5 Middle East & Africa
  • 1.4 Data Sources
    • 1.4.1 Primary
    • 1.4.2 Data mining sources
      • 1.4.2.1 Paid sources
      • 1.4.2.2 Public sources

Chapter 2 Executive Summary

  • 2.1 Minoxidil industry 360 degree synopsis, 2022
    • 2.1.1 Business trends
    • 2.1.2 Regional trends
    • 2.1.3 Product trends

Chapter 3 Minoxidil Industry Insights

  • 3.1 Industry segmentation
  • 3.2 COVID-19 impact on the world economy
  • 3.3 Industry ecosystem analysis
    • 3.3.1 Raw materials
    • 3.3.2 Manufacturers
    • 3.3.3 Distributors
    • 3.3.4 Distribution channel analysis
    • 3.3.5 Profit margin trend
    • 3.3.6 Vendor matrix
    • 3.3.7 Impact of COVID-19 on value chain
  • 3.4 Raw material analysis
    • 3.4.1 Impact of COVID-19 on the raw material supply
  • 3.5 Technology landscape
    • 3.5.1 Potential application scenario
      • 3.5.1.1 Minoxidil for beard growth
      • 3.5.1.2 Alternative minoxidil formulations
    • 3.5.2 Formulation process
    • 3.5.3 Solid lipid nanoparticles
    • 3.5.4 Propylene glycol minoxidil topical formulation for hair loss
  • 3.6 Global alopecia industry scenario
    • 3.6.1 Minoxidil vs other hair loss treatments
      • 3.6.1.1 Dermatology uses of minoxidil
        • 3.6.1.1.1 Hair transplant
        • 3.6.1.1.2 Alopecia areata
      • 3.6.1.2 Minoxidil side effects
      • 3.6.1.3 Other hair loss treatments
        • 3.6.1.3.1 Androgen-dependent medications
      • 3.6.1.4 New users % for 2018, 2019, 2020, 2021, and 2022
        • 3.6.1.4.1 Demographic trends
        • 3.6.1.4.2 Consumer buying behavior
        • 3.6.1.4.2.1 Unmet needs
        • 3.6.1.4.2.2 Social & cultural impact forces
        • 3.6.1.4.2.3 Information search
        • 3.6.1.4.2.4 Evaluation of alternative
        • 3.6.1.4.2.5 Purchase decision
        • 3.6.1.4.2.6 Post-purchase evaluation
    • 3.6.2 Impact of COVID-19 on the consumer buying behaviour
  • 3.7 Industry best practices & key buying criteria
  • 3.8 Regulatory landscape
    • 3.8.1 North America
      • 3.8.1.1 Department of Health and Human Services (NDA 021812/S-009)
    • 3.8.2 Europe
      • 3.8.2.1 Medicines & Healthcare products Regulatory Agency (PL 15513/0135-0020)
    • 3.8.3 Asia Pacific
      • 3.8.3.1 Pharmaceutical and Medical Devices Agency (PMDA)
    • 3.8.4 Latin America
      • 3.8.4.1 The Argentine Law of Lealtad Commercial
      • 3.8.4.2 Brazil Regulation 335/99
    • 3.8.5 Middle East & Africa
      • 3.8.5.1 Saudi Food & Drug Authority (SFDA)
  • 3.9 Pricing analysis, by region
    • 3.9.1 5% minoxidil
    • 3.9.2 2% minoxidil
    • 3.9.3 Cost structure analysis
    • 3.9.4 Impact of COVID-19 on regional pricing
  • 3.10 Industry impact forces
    • 3.10.1 Growth drivers
      • 3.10.1.1 Growing consumer spending on hair care products accompanied by the expanding distribution channel
      • 3.10.1.2 Developing personal care market along with the increasing prevalence of alopecia areata
    • 3.10.2 Industry pitfall
      • 3.10.2.1 Stringent regulations along with possible side effects of minoxidil
  • 3.11 Innovation & sustainability
  • 3.12 Growth potential analysis, 2022
  • 3.13 Porter's analysis
    • 3.13.1 Threat of new entrants
    • 3.13.2 Supplier power
    • 3.13.3 Buyer power
    • 3.13.4 Threat of substitutes
  • 3.14 PESTEL analysis
  • 3.15 Impact of COVID-19 on the cosmetics industry
  • 3.16 Impact of the Russia-Ukraine war on the minoxidil market

Chapter 4 Competitive Landscape, 2022

  • 4.1 Introduction
  • 4.2 Company market share analysis, 2022
    • 4.2.1 North America company market share analysis, 2022
    • 4.2.2 Europe company market share analysis, 2022
    • 4.2.3 APAC company market share analysis, 2022
    • 4.2.4 LATAM company market share analysis, 2022
    • 4.2.5 MEA company market share analysis, 2022
  • 4.3 Competitive analysis of major market players
    • 4.3.1 Johnson & Johnson Consumer Inc.
    • 4.3.2 Costco Wholesale Corporation
    • 4.3.3 Perrigo Company Plc
    • 4.3.4 Pfizer
    • 4.3.5 Renata
  • 4.4 Competitive positioning matrix
  • 4.5 Strategic outlook matrix

Chapter 5 Minoxidil Market, By Product

  • 5.1 Key product trends
  • 5.2 5%
    • 5.2.1 Market estimates & forecast, 2018-2032, (Thousand Units) (USD Million)
    • 5.2.2 Market estimates & forecast, by region, 2018-2032, (Thousand Units) (USD Million)
  • 5.3 2%
    • 5.3.1 Market estimates & forecast, 2018-2032, (Thousand Units) (USD Million)
    • 5.3.2 Market estimates & forecast, by region, 2018-2032, (Thousand Units) (USD Million)

Chapter 6 Minoxidil Market, By Region

  • 6.1 Key regional trends
  • 6.2 North America
    • 6.2.1 North America minoxidil market estimates & forecast, 2018-2032, (Thousand Units) (USD Million)
    • 6.2.2 North America minoxidil market estimates & forecast, by product, 2018-2032, (Thousand Units) (USD Million)
    • 6.2.3 U.S.
      • 6.2.3.1 U.S. minoxidil market estimates & forecast, 2018-2032, (Thousand Units) (USD Million)
      • 6.2.3.2 U.S. minoxidil market estimates & forecast, by product, 2018-2032, (Thousand Units) (USD Million)
    • 6.2.4 Canada
      • 6.2.4.1 Canada minoxidil market estimates & forecast, 2018-2032, (Thousand Units) (USD Million)
      • 6.2.4.2 Canada minoxidil market estimates & forecast, by product, 2018-2032, (Thousand Units) (USD Million)
  • 6.3 Europe
    • 6.3.1 Europe minoxidil market estimates & forecast, 2018-2032, (Thousand Units) (USD Million)
    • 6.3.2 Europe minoxidil market estimates & forecast, by product, 2018-2032, (Thousand Units) (USD Million)
    • 6.3.3 Germany
      • 6.3.3.1 Germany minoxidil market estimates & forecast, 2018-2032, (Thousand Units) (USD Million)
      • 6.3.3.2 Germany minoxidil market estimates & forecast, by product, 2018-2032, (Thousand Units) (USD Million)
    • 6.3.4 UK
      • 6.3.4.1 UK minoxidil market estimates & forecast, 2018-2032, (Thousand Units) (USD Million)
      • 6.3.4.2 UK minoxidil market estimates & forecast, by product, 2018-2032, (Thousand Units) (USD Million)
    • 6.3.5 France
      • 6.3.5.1 France minoxidil market estimates & forecast, 2018-2032, (Thousand Units) (USD Million)
      • 6.3.5.2 France minoxidil market estimates & forecast, by product, 2018-2032, (Thousand Units) (USD Million)
    • 6.3.6 Italy
      • 6.3.6.1 Italy minoxidil market estimates & forecast, 2018-2032, (Thousand Units) (USD Million)
      • 6.3.6.2 Italy minoxidil market estimates & forecast, by product, 2018-2032, (Thousand Units) (USD Million)
    • 6.3.7 Spain
      • 6.3.7.1 Spain minoxidil market estimates & forecast, 2018-2032, (Thousand Units) (USD Million)
      • 6.3.7.2 Spain minoxidil market estimates & forecast, by product, 2018-2032, (Thousand Units) (USD Million)
    • 6.3.8 Russia
      • 6.3.8.1 Russia minoxidil market estimates & forecast, 2018-2032, (Thousand Units) (USD Million)
      • 6.3.8.2 Russia minoxidil market estimates & forecast, by product, 2018-2032, (Thousand Units) (USD Million)
    • 6.3.9 Poland
      • 6.3.9.1 Poland minoxidil market estimates & forecast, 2018-2032, (Thousand Units) (USD Million)
      • 6.3.9.2 Poland minoxidil market estimates & forecast, by product, 2018-2032, (Thousand Units) (USD Million)
  • 6.4 Asia Pacific
    • 6.4.1 Asia Pacific minoxidil market estimates & forecast, 2018-2032, (Thousand Units) (USD Million)
    • 6.4.2 Asia Pacific minoxidil market estimates & forecast, by product, 2018-2032, (Thousand Units) (USD Million)
    • 6.4.3 China
      • 6.4.3.1 China minoxidil market estimates & forecast, 2018-2032, (Thousand Units) (USD Million)
      • 6.4.3.2 China minoxidil market estimates & forecast, by product, 2018-2032, (Thousand Units) (USD Million)
    • 6.4.4 India
      • 6.4.4.1 India minoxidil market estimates & forecast, 2018-2032, (Thousand Units) (USD Million)
      • 6.4.4.2 India minoxidil market estimates & forecast, by product, 2018-2032, (Thousand Units) (USD Million)
    • 6.4.5 Japan
      • 6.4.5.1 Japan minoxidil market estimates & forecast, 2018-2032, (Thousand Units) (USD Million)
      • 6.4.5.2 Japan minoxidil market estimates & forecast, by product, 2018-2032, (Thousand Units) (USD Million)
    • 6.4.6 South Korea
      • 6.4.6.1 South Korea minoxidil market estimates & forecast, 2018-2032, (Thousand Units) (USD Million)
      • 6.4.6.2 South Korea minoxidil market estimates & forecast, by product, 2018-2032, (Thousand Units) (USD Million)
    • 6.4.7 Australia
      • 6.4.7.1 Australia minoxidil market estimates & forecast, 2018-2032, (Thousand Units) (USD Million)
      • 6.4.7.2 Australia minoxidil market estimates & forecast, by product, 2018-2032, (Thousand Units) (USD Million)
    • 6.4.8 Indonesia
      • 6.4.8.1 Indonesia minoxidil market estimates & forecast, 2018-2032, (Thousand Units) (USD Million)
      • 6.4.8.2 Indonesia minoxidil market estimates & forecast, by product, 2018-2032, (Thousand Units) (USD Million)
    • 6.4.9 Thailand
      • 6.4.9.1 Thailand minoxidil market estimates & forecast, 2018-2032, (Thousand Units) (USD Million)
      • 6.4.9.2 Thailand minoxidil market estimates & forecast, by product, 2018-2032, (Thousand Units) (USD Million)
    • 6.4.10 Malaysia
      • 6.4.10.1 Malaysia minoxidil market estimates & forecast, 2018-2032, (Thousand Units) (USD Million)
      • 6.4.10.2 Malaysia minoxidil market estimates & forecast, by product, 2018-2032, (Thousand Units) (USD Million)
  • 6.5 Latin America
    • 6.5.1 Latin America minoxidil market estimates & forecast, 2018-2032, (Thousand Units) (USD Million)
    • 6.5.2 Latin America minoxidil market estimates & forecast, by product, 2018-2032, (Thousand Units) (USD Million)
    • 6.5.3 Brazil
      • 6.5.3.1 Brazil minoxidil market estimates & forecast, 2018-2032, (Thousand Units) (USD Million)
      • 6.5.3.2 Brazil minoxidil market estimates & forecast, by product, 2018-2032, (Thousand Units) (USD Million)
    • 6.5.4 Mexico
      • 6.5.4.1 Mexico minoxidil market estimates & forecast, 2018-2032, (Thousand Units) (USD Million)
      • 6.5.4.2 Mexico minoxidil market estimates & forecast, by product, 2018-2032, (Thousand Units) (USD Million)
    • 6.5.5 Argentina
      • 6.5.5.1 Argentina minoxidil market estimates & forecast, 2018-2032, (Thousand Units) (USD Million)
      • 6.5.5.2 Argentina minoxidil market estimates & forecast, by product, 2018-2032, (Thousand Units) (USD Million)
  • 6.6 Middle East & Africa
    • 6.6.1 Middle East & Africa minoxidil market estimates & forecast, 2018-2032, (Thousand Units) (USD Million)
    • 6.6.2 Middle East & Africa minoxidil market estimates & forecast, by product, 2018-2032, (Thousand Units) (USD Million)
    • 6.6.3 Saudi Arabia
      • 6.6.3.1 Saudi Arabia minoxidil market estimates & forecast, 2018-2032, (Thousand Units) (USD Million)
      • 6.6.3.2 Saudi Arabia minoxidil market estimates & forecast, by product, 2018-2032, (Thousand Units) (USD Million)
    • 6.6.4 UAE
      • 6.6.4.1 UAE minoxidil market estimates & forecast, 2018-2032, (Thousand Units) (USD Million)
      • 6.6.4.2 UAE minoxidil market estimates & forecast, by product, 2018-2032, (Thousand Units) (USD Million)
    • 6.6.5 South Africa
      • 6.6.5.1 South Africa minoxidil market estimates & forecast, 2018-2032, (Thousand Units) (USD Million)
      • 6.6.5.2 South Africa minoxidil market estimates & forecast, by product, 2018-2032, (Thousand Units) (USD Million)

Chapter 7 Company Profiles

  • 7.1 Nanz Med Science Pharma Private Limited
    • 7.1.1 Business Overview
    • 7.1.2 Financial Data
    • 7.1.3 Product Landscape
    • 7.1.4 SWOT Analysis
  • 7.2 Bakul Group of companies
    • 7.2.1 Business Overview
    • 7.2.2 Financial Data
    • 7.2.3 Product Landscape
    • 7.2.4 SWOT Analysis
  • 7.3 Kumar Organic Products Limited
    • 7.3.1 Business Overview
    • 7.3.2 Financial Data
    • 7.3.3 Product Landscape
    • 7.3.4 SWOT Analysis
  • 7.4 Changzhou Tianhua Pharmaceutical Co., Ltd.
    • 7.4.1 Business Overview
    • 7.4.2 Financial Data
    • 7.4.3 Product Landscape
    • 7.4.4 SWOT Analysis
  • 7.5 Par Pharmaceuticals
    • 7.5.1 Business Overview
    • 7.5.2 Financial Data
    • 7.5.3 Product Landscape
    • 7.5.4 SWOT Analysis
  • 7.6 Provizer Pharma
    • 7.6.1 Business Overview
    • 7.6.2 Financial Data
    • 7.6.3 Product Landscape
    • 7.6.4 SWOT Analysis
  • 7.7 Metapharmaceutical Ind. S.L.
    • 7.7.1 Business Overview
    • 7.7.2 Financial Data
    • 7.7.3 Product Landscape
    • 7.7.4 SWOT Analysis
  • 7.8 Pharhome International Limited
    • 7.8.1 Business Overview
    • 7.8.2 Financial Data
    • 7.8.3 Product Landscape
    • 7.8.4 SWOT Analysis
  • 7.9 LOY Pharma Lab, Inc.
    • 7.9.1 Business Overview
    • 7.9.2 Financial Data
    • 7.9.3 Product Landscape
    • 7.9.4 SWOT Analysis
  • 7.10 Maruti Futuristic Pharma Pvt. Ltd.
    • 7.10.1 Business Overview
    • 7.10.2 Financial Data
    • 7.10.3 Product Landscape
    • 7.10.4 SWOT Analysis
  • 7.11 Dr. R. Pfleger Chemical Factory GmbH
    • 7.11.1 Business Overview
    • 7.11.2 Financial Data
    • 7.11.3 Product Landscape
    • 7.11.4 SWOT Analysis
  • 7.12 Renata Limited
    • 7.12.1 Business Overview
    • 7.12.2 Financial Data
    • 7.12.3 Product Landscape
    • 7.12.4 Strategic Outlook
    • 7.12.5 SWOT Analysis
  • 7.13 McNeil Consumer Healthcare
    • 7.13.1 Business Overview
    • 7.13.2 Financial Data
    • 7.13.3 Product Landscape
    • 7.13.4 SWOT Analysis
  • 7.14 Pfizer
    • 7.14.1 Business Overview
    • 7.14.2 Financial Data
    • 7.14.3 Product Landscape
    • 7.14.4 SWOT Analysis